Has Lillian Tran, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,018 in general payments to Lillian Tran, MD across 30 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lillian Tran, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lillian Tran, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lillian Tran, MD

Cornea and External Diseases Specialist · Sacramento, CANPI 1477041127

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Alcon at 43.4% of the total. That places this record below the midpoint for cornea and external diseases specialist clinicians in CA, where the typical reported total is $4,024.

$2,018in general payments, 2019–2025

Across 30 payments — averaging $67.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$875
Glaukos Corporation$219
Sun Pharmaceutical Industries Inc.$179
Sight Sciences, Inc.$170
Apellis Pharmaceuticals, Inc.$115
Regeneron Healthcare Solutions, Inc.$109
plus $350 from 7 others

What the payments were for

Food & beverage$1,91895%
Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	10	$875
Glaukos Corporation	5	$219
Sun Pharmaceutical Industries Inc.	3	$179
Sight Sciences, Inc.	2	$170
Apellis Pharmaceuticals, Inc.	1	$115
Regeneron Healthcare Solutions, Inc.	1	$109
AbbVie	1	$100
Aroa Biosurgery Incorporated	2	$89
Ivantis, Inc	1	$43
Carl Zeiss Meditec USA, Inc.	1	$41
Carl Zeiss Meditec, Inc.	1	$36
Aerie Pharmaceuticals, Inc.	1	$25
Alimera Sciences, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,018 in reported general payments places this provider in the 35th percentile of 50 cornea and external diseases specialist providers in California.

See all cornea and external diseases specialist providers in California →

Medicare billing

Part B allowed, 2024

$49,247

Medicare patients

Services billed

125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	117	$4,946
Cyclosporine	18	$3,851
Ketorolac Tromethamine	37	$2,024
MoxifloxacinMoxifloxacin Hcl	56	$893
Fluorometholone	15	$863
Latanoprost	47	$856
Dorzolamide-TimololDorzolamide/Timolol/Pf	12	$834
ErythromycinErythromycin Base	15	$209
Timolol Maleate	18	$69
Azelastine Hcl	11	$58

Paid to pharmacies, not to this prescriber.

Other cornea and external diseases specialist in Sacramento

Peter AndrewsSacramento$14K
Bradley BarnettSacramento$12K
Jeffrey MaSacramento$1K
Mathew MargolisSacramento$1K
Milad ModabberSacramento$965
Erika EllisSacramento$372
Sumit GargIrvine$808K
Jillian ChongBeverly Hills$113K
Tyson KimSan Francisco$91K
Edward MancheStanford$78K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →